NCT05581004
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT04542837
The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma treatment 2 completed NCT06184152
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules No drug interventions diagnostic Not Available recruiting NCT06584071
A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC treatment 1 / 2 not_yet_recruiting NCT06617000
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related No drug interventions treatment 1 recruiting NCT05401890
Association Between Serum Ferritin Level and Severity of Liver Disease and Development of HCC in Cirrhotic Patients No drug interventions Not Available Not Available unknown_status NCT02232490
Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L treatment 3 unknown_status NCT06523179
Evaluation of Risk of hEpatocellular Carcinoma No drug interventions prevention Not Available recruiting NCT02182687
Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant treatment 2 completed NCT05840133
Study of Long Non-coding RNA SNHG15 as a Novel Biomarker in HBV Associated HCC No drug interventions Not Available Not Available not_yet_recruiting NCT02977754
18F-FDG PET in HCC Patients Candidate to Treatment With Sorafenib No drug interventions Not Available Not Available completed NCT06069947
SALT for Liver Cirrhosis With HCC No drug interventions treatment Not Available not_yet_recruiting NCT02833298
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening No drug interventions prevention Not Available completed NCT03601598
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC treatment 1 / 2 unknown_status NCT02705105
Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 completed NCT02415283
OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI No drug interventions Not Available Not Available unknown_status NCT05022628
Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis treatment 4 unknown_status NCT01356628
A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer treatment 2 active_not_recruiting NCT04195971
Dual Arterial Phase Liver CT in Patients With Suspected Portal Hypertension No drug interventions diagnostic Not Available unknown_status NCT05592171
Occlusafe® Assisted MW Alone or With DEB-TACE Compared to MW With DEB-TACE in the Treatment of HCC No drug interventions treatment Not Available recruiting NCT02935478
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation No drug interventions treatment Not Available suspended NCT05202015
Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study No drug interventions Not Available Not Available unknown_status NCT05458115
Clinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT04455932
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation No drug interventions screening Not Available recruiting NCT02659852
A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction No drug interventions treatment Not Available unknown_status NCT06285149
Tace With Icaritin in First-line Treatment of Middle and Advanced HCC in Child Grade B Patients treatment 2 not_yet_recruiting NCT03817736
Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy No drug interventions treatment 2 completed NCT02471313
Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization No drug interventions diagnostic 2 completed NCT03875417
Multidisciplinary Management of HCC in Elderly Patients No drug interventions Not Available Not Available completed NCT04251117
GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC treatment 1 / 2 active_not_recruiting NCT04390724
Optimizing Y90 Therapy for Radiation Lobectomy No drug interventions Not Available Not Available recruiting NCT06311916
Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model. treatment 4 not_yet_recruiting NCT02971696
Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients. treatment 3 completed NCT02575339
MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma treatment 1 / 2 terminated NCT03108248
ISP-TACE Versus TACE for HCC With PVTT Not Available Not Available completed NCT03097848
Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma treatment Not Available unknown_status NCT04165174
PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT treatment 2 unknown_status NCT05450874
A Novel MSE Score to Predict rHCC Patients No drug interventions Not Available Not Available completed NCT03104920
ERAS Program Improves Recovery of HCC Patient Undergoing Hepatectomy No drug interventions treatment Not Available unknown_status NCT02675920
A Study of HCC High Risk Group Using Two Surveillance Tools Not Available Not Available completed NCT05227482
Accurate Dosimetry and Biomarkers Improve Survival in HCC Patients Treated With Resin 90 Yttrium (90Y)-Microspheres No drug interventions treatment 2 unknown_status NCT03437382
Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study No drug interventions treatment Not Available completed NCT04611373
Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC treatment 3 unknown_status NCT03274427
Treatment of Intermediate-stage Hepatocellular Carcinoma treatment 3 unknown_status NCT06560827
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection No drug interventions treatment 1 recruiting NCT02675894
Radiofrequency Ablation Using Cooled-Wet Electrode No drug interventions treatment Not Available completed NCT04326491
The Utility of Breath Biopsy as a Screening Tool for HCC No drug interventions Not Available Not Available completed NCT06434480
SBRT in HCC With Oligoprogression on Atezo-Bev No drug interventions treatment Not Available recruiting NCT06311929
Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma treatment 4 recruiting NCT05025592
cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC Not Available Not Available unknown_status NCT02715492
Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. prevention 3 unknown_status NCT05873244
CXD101 in Immunotherapy-related Liver Cancer treatment 2 recruiting NCT05402644
Hepatectomy for Early-stage HCC Patients With CSPH No drug interventions Not Available Not Available completed NCT06463444
Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models treatment 1 recruiting NCT04530240
Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy No drug interventions Not Available Not Available completed NCT04123340
Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation No drug interventions treatment 2 completed NCT05781568
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available recruiting NCT02675881
Monopolar Radiofrequency Ablation Using a Dual Switching System and a Separable Clustered Electrode (Octopus®) No drug interventions treatment Not Available completed NCT01470495
Combined Treatment of RFA and Sorafenib on Recurrent HCC No drug interventions other Not Available unknown_status NCT03960008
Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant treatment 3 terminated NCT05178043
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT06253364
VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy Not Available Not Available completed NCT03428321
Small and Steatotic Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT05202184
Non Transplantable Recurrence After Percutaneous Thermal Ablation of HCC No drug interventions Not Available Not Available completed NCT03414554
Risk of HCC in Cirrhotic Patients Post DAAs Ttt No drug interventions Not Available Not Available unknown_status NCT04588051
Cabozantinib in Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT05544253
Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC No drug interventions prevention 2 / 3 unknown_status NCT06184347
Population-wide Research for HBV-related Liver Diseases in Maoming City No drug interventions Not Available Not Available not_yet_recruiting NCT04988945
TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma treatment 2 recruiting NCT01871545
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI) No drug interventions diagnostic Not Available completed NCT03045445
"Double Low-Dose" DECT for HCC Imaging No drug interventions diagnostic Not Available completed NCT06581497
ICIs With and Without MWA in Advanced Hepatocellular Carcinoma No drug interventions Not Available Not Available active_not_recruiting NCT02229071
Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma treatment 1 / 2 completed NCT05637788
Artificial Intelligence and Hepatocellular Carcinoma No drug interventions Not Available Not Available active_not_recruiting NCT05965388
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy Not Available Not Available not_yet_recruiting NCT03199807
Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC No drug interventions treatment 1 / 2 unknown_status NCT03176485
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors No drug interventions prevention Not Available completed NCT02898415
Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available completed NCT03314532
The Efficacy of Hepatectomy or TILA-TACE in Patients With Resectable Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT06024252
Efficacy, Safety, and Treatment Patterns of Transcatheter Arterial Chemoembolization (TACE) Combined With Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma: a Multicenter, Retrospective, Observational Real-world Study Not Available Not Available not_yet_recruiting NCT05199259
Multi-analyte Blood Test Clinical Trial No drug interventions Not Available Not Available recruiting NCT06311942
Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC. treatment 4 recruiting NCT04172506
A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors treatment 1 / 2 completed NCT06461936
Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC Not Available Not Available active_not_recruiting NCT04766736
Netrin-1 & Hepatocellular Carcinoma HCC No drug interventions Not Available Not Available unknown_status NCT03950518
Novel Treatment of Advanced Hepatocellular Carcinoma treatment 3 unknown_status NCT03045419
Added Value of Gadoxetic Acid-enhanced Liver MRI No drug interventions Not Available Not Available completed NCT06413017
Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure treatment 2 recruiting NCT02985034
Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT No drug interventions Not Available Not Available completed NCT04069416
Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria No drug interventions Not Available Not Available completed NCT05825196
Study of Serum Tumor Markers of HBV Associated HCC No drug interventions Not Available Not Available not_yet_recruiting NCT05788835
DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial No drug interventions treatment Not Available recruiting NCT04640363
Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study No drug interventions Not Available Not Available unknown_status NCT05212922
A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC treatment 2 withdrawn NCT04232722
Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation treatment 2 unknown_status NCT06008548
A New Conception About Individualized Treatment Allocation for HCC No drug interventions Not Available Not Available completed NCT05341557
A Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory Lymphoma No drug interventions treatment 1 not_yet_recruiting NCT05471674
Neoadjuvant Anti-PD1 in HCC treatment 2 completed NCT02785874
Statin With Palliative Therapy for HCC treatment Not Available terminated NCT04173520
ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy No drug interventions Not Available Not Available completed NCT04843176
Artificial Intelligence vs. LIRADS in Diagnosing HCC on CT No drug interventions diagnostic Not Available recruiting NCT01265576
Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT04032860
RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection treatment 4 active_not_recruiting NCT02548780
LifePearl-Doxo Pharmacokinetic (PK) Study No drug interventions treatment Not Available completed NCT03985644
Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT04522544
Durvalumab and Tremelimumab in Combination With Either Y-90 SIRT or DEB-TACE for Intermediate Stage HCC treatment 2 recruiting NCT03278444
Treatment of Advanced Hepatocellular Carcinoma treatment 3 unknown_status NCT06420440
Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model treatment 2 not_yet_recruiting NCT04472767
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma treatment 2 recruiting NCT02561546
p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT04682210
Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection treatment 3 not_yet_recruiting NCT03419481
Pembrolizumab in Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT02645981
Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma treatment 2 / 3 completed NCT02187081
Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC No drug interventions treatment Not Available unknown_status NCT03893695
Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC) treatment 1 / 2 completed NCT06527495
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT04024514
Renal Protocol Protection in CKD Patients No drug interventions diagnostic Not Available active_not_recruiting NCT04172714
Low-dose Y90 Treatment Planning for HCC No drug interventions treatment Not Available completed NCT02256514
Open Label Trial of Immunotherapy for Advanced Liver Cancer treatment 2 unknown_status NCT01387555
A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib treatment 2 completed NCT02966223
A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver No drug interventions diagnostic Not Available terminated